For Pharma and Biotech companies, the importance of maintaining regulatory compliance cannot not be understated, especially when working in the area of patient communication. I work to an ethos of ethical compliance, due diligence and added value, always with an eye to the resources available.
The three keys to building successful compliant patient engagement partnerships are:
I was the principal author of a peer review publication which identified these three elements as the most important determinants of a compliant Phase III advocacy strategy as seen by Industry and Patient Groups themselves.
Journal Market Access and Health Policy 2016 4 33177